Success cases
Disruptive drug for osteoporosis
A start-up expert in micro-RNA wants to evaluate the applicability of its technology in the field of osteoporosis.
Challenge
Micro-RNA-based therapies are in full expansion and applied for different therapeutic uses. A leading start-up in this field wants to evaluate new business opportunities.
The field of osteoporosis could be fascinating both for its associated market and for the suitability of applying micro-RNA-based therapies.
Solution
Solution After analysing the methodology developed by the start-up and how it could be applied to the specific case of osteoporosis, a thorough market study was carried out.
The osteoporosis market was quantified, and the state-of-the-art, existing therapeutic arsenal, pipeline, opportunities, and niches to be targeted were determined.
We defined which type of micro-RNAs may be related to osteoporosis-related metabolic pathways.
Result
- Document with quantification of the osteoporosis market, players, competitors, pipeline opportunities and unmet medical needs.
- Compilation of micro-RNAs that may have a relevant role according to different metabolic pathways.
- Opinion regarding the suitability of initiating specific in-house programs related to osteoporosis. Disruptive drug for osteoporosis
“Defined which type of micro-RNAs may be related to metabolic pathways associated with osteoporosis.”
Success case studies in the sector Biotech
success stories Market analysis